FHIT Suppresses Epithelial-Mesenchymal Transition (EMT) and Metastasis in Lung Cancer through Modulation of MicroRNAs

PLoS Genetics

Volumn 10, Issue 10, 2014, Pages

  Suh, Sung Suk ^a,b   Yoo, Ji Young ^c   Cui, Ri ^a   Kaur, Balveen ^c   Huebner, Kay ^a   Lee, Taek Kyun ^b   Aqeilan, Rami I ^a,d   Croce, Carlo M ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b Korea Research Institute of Ships and Ocean Engineering   (South Korea)

^c THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; FRAGILE HISTIDINE TRIAD PROTEIN; HIGH MOBILITY GROUP A2 PROTEIN; METADHERIN; MICRORNA; MICRORNA 30C; ONCOPROTEIN; UNCLASSIFIED DRUG; VIMENTIN; ACID ANHYDRIDE HYDROLASE; CELL ADHESION MOLECULE; MIRN30 MICRORNA, HUMAN; MTDH PROTEIN, HUMAN; TUMOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GENE THERAPY; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFICACY; DRUG POTENCY; DRUG PROTEIN BINDING; DRUG TARGETING; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; FHIT GENE; FN1 GENE; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE INTERACTION; GENE TARGETING; GENETIC CORRELATION; GENETIC MARKER; HMGA2 GENE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; MTDH GENE; NONHUMAN; PROTEIN RNA BINDING; RNA GENE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE; UPREGULATION; VIM GENE; BIOSYNTHESIS; GENETICS; LUNG TUMOR; METASTASIS; PATHOLOGY; TUMOR CELL LINE;

ACID ANHYDRIDE HYDROLASES; CELL ADHESION MOLECULES; CELL LINE, TUMOR; EPITHELIAL-MESENCHYMAL TRANSITION; FIBRONECTINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HMGA2 PROTEIN; HUMANS; LUNG NEOPLASMS; MICRORNAS; NEOPLASM METASTASIS; NEOPLASM PROTEINS; VIMENTIN;

EID: 84908319614     PISSN: 15537390     EISSN: 15537404     Source Type: Journal    
DOI: 10.1371/journal.pgen.1004652     Document Type: Article

References (36)

1. Chambers AF, Groom AC, MacDonald CM, (2002) Dissemination and growth of cancer cells in metastatic sites. Nature Rev Cancer 2: 563–572.
2. Folkman J, (2002) The role of angiogenesis in tumor growth and metastasis. Semin Oncol 29: 15–18.
3. Polyak K, Weinberg RA, (2009) Transition between epithelial and mesenchymal states: acquisition of malignant and stem cell traits. Nature Rev Cancer 9: 265–273.
4. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, et al. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 16: 704–715.
5. Kalluri R, (2009) EMT: When epithelial cells decide to become mesenchymal-like cells. J Clin Invest 119: 1417–1419.
6. Zavadil J, Bottinger EP, (2005) TGF-beta and epithelial-to mesenchymal transitions. Oncogene 29: 5764–5774.
7. Gregory PA, Bert AG, Paterson EL, Barry SC, Tsykin A, et al. (2008) The miR-200 family and miR-205 regulate epithelial to meshenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 10: 593–601.
8. Siemens H, Jackstadt R, Hunten S, Kaller M, Menssen A, et al. (2010) miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle 10: 4256–4271.
9. Edmonds MD, Hurst DR, Vaidya KS, Stafford LJ, Chen D, et al. (2009) Breast cancer metastasis suppressor 1 coordinately regulates metastasis-associated microRNA expression. Int J Cancer 125: 1778–1785.
10. Zhang JG, Wang JJ, Zhao F, Liu Q, Jiang K, et al. (2010) MicroRNA-21(miR-21) represses tumor suppressor PTEN and promote growth and invasion in non-small cell lung cancer (NSCLC). Clin Chim Acta 411: 846–852.
11. Sampson VB, Rong NH, Han J, Yang Q, Aris V, et al. (2007) MicroRNA Let-7a down-regulates MYC and reverts MYC-induced growth in burkitt lymphoma cells. Cancer Res 67: 9762–9770.
12. Lee YS, Dutta A, (2007) The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev 21: 1025–1030.
13. Lagana A, Russo F, Sismeiro C, Giuqno R, Puvirenti A, et al. (2010) Variability in the incidence of miRNAs and genes in fragile sites and the role of repeats and CpG islands in the distribution of genetic material. PLos One 5: e11166.
14. Starczynowski DT, Morin R, McPherson A, Lam J, Chari R, et al. (2011) Genome-wide identification of human microRNAs located in leukemia-associated genomic alterations. Blood 117: 595–607.
15. Ohta M, Inoue H, Cotticelli MG, Kastury K, Baffa R, et al. (1996) The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal carcinoma-associated t (3; 8) breakpoint, is abnormal in digestive tract cancers. Cell 84: 587–597.
16. Sozzi G, Veronese ML, Negrini M, Baffa R, Cotticelli MG, et al. (1996) The FHIT gene 3p14.2 is abnormal in lung cancer. Cell 85: 17–26.
17. Negrini M, Monaco C, Vorechovsky I, Ohta M, Druck T, et al. (1996) The FHIT gene at 3p14.2 is abnormal in breast carcinoma. Cancer Res 56: 3173–3179.
18. Song X, Tian Z, Wang S, Peng Z, Feng J, (2010) Restoration of fragile histidine triad (FHIT) expression inhibits cell growth and induces apoptosis in cutaneous T-cell lymphoma cell line. Cancer Invest 28: 1019–1023.
19. Joannes A, Bonnomet A, Bindels S, Polette M, Gilles C, et al. (2010) Fhit regulates invasion of lung tumor cells. Oncogene 29: 1203–1213.
20. Joannes A, Grelet S, Duca L, Gilles C, Kileztky C, et al. (2014) Fhit regulates EMT targets through an EGFR/Src/ERK/Slug signaling axis in human bronchial cells. Mol Cancer Res 12: 775–783.
21. Xu J, Lamouille S, Derynck R, (2009) TGF-β-induced epithelial to mesenchymal transition. Cell Res 19: 156–172.
22. Katsuno Y, Lamouilles S, Derynck R, (2013) TGF-β signaling and epithelial-mesenchymal transition in cancer progression. Curr Opin Oncol 25: 76–84.
23. Antonov AV, Knight RA, Melino G, Barlev NA, Tsvetkov PO (2012). MIRUMIR: an online tool to test microRNAs as biomarkers to predict survival in cancer using multiple clinical data sets. Cell Death Differ. Doi:10.1038/cdd.2012.137.
24. Gyorffy B, Lanczky A, Eklund AC, Denkert C, Budczies J, et al. (2010) An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1.809 patients. Breast Cancer Res Treatment 123: 725–731.
25. Hu G, Chong RA, Yang Q, Wei Y, Blanco MA, et al. (2009) MTDH activation by 8q22 genomic gain promotes chemoresistance and metastasis of poor-prognosis breast cancer. Cancer Cell 15: 9–20.
26. Hristov AC, Cope L, Reyes MD, Singh M, Lacobuzio-Donahue C, et al. (2009) HMGA2 protein expression correlates with lymph node metastasis and increased tumor grade in pancreatic ductal adenocarcinoma. Mod Pathol 22: 43–49.
27. Dumon KR, Ishii H, Fong LY, Zanesi N, Fidanza V, et al. (2001) FHIT gene therapy prevents tumor development in Fhit-deficient mice. Proc Natl Acad Sci USA 98: 3346–3351.
28. Toledo G, Sola JJ, Lozano MD, Soria E, Pardo J, (2004) Loss of FHIT protein expression is related to high proliferation, low apoptosis and worse prognosis in non-small- cell lung cancer. Mod Pathol 17: 440–448.
29. Bekar A, Cecener G, Tunca B, Guler G, Egeli U, et al. (2007) Investigation of mutations and expression of the FHIT gene in Turkish patients with brain metastases derived from non-small cell lung cancer. Tumori 93: 604–607.
30. Zhao P, Li XY, Chen LZ, (2002) Loss of fragile histidine triad expression and metastasis in breast cancer. Ai Zheng 21: 668–670.
31. Yu F, Deng H, Yao H, Liu Q, Su F, et al. (2010) Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells. Oncogene 29: 4194–4204.
32. Bochhorn J, Dalton R, Nwachukwu C, Huang S, Prat A, et al. (2013). MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11. Nat Commun.4, Article number 1393.
33. Budhu A, Jia HL, Forques M, Liu CG, Goldstein D, et al. (2008) Identification of metastasis-related microRNAs in hepatocellular carcinoma. Hepatology 47: 897–907.
34. Joqlekar KV, Patil D, Joqlekar VM, Rao GV, Reddy DN, et al. (2009) The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells. Islets 1: 137–147.
35. Zhang J, Zhang H, Liu J, Tu X, Zhang Y, et al. (2012) miR-30 inhibits TGF-β1-induced epithelial-to-mesenchymal transition in hepatocyte by targeting Snail1. Biochem Biophys Res Commun 417: 1100–1105.
36. Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, et al. (2005) Genes that mediate breast cancer metastasis to lung. Nature 436: 518–524.